Evaluation of Circulating Vegf Based Biomarkers in Integrate: A Randomized Phase Ii Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Oesophagogastric Cancer (Aogc)-a Study by the Australasian Gastrointestinal Trials Group (Agitg).